Incyte Biosciences UK Ltd

Incyte is a global biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. World-class science and R&D drive Incyte’s business and its commitment to making a difference in the lives of patients through scientific discovery.

We have an experienced team with a track record of success, and our goal is to create first-in-class and best-in-class therapeutics to meet serious unmet medical needs in oncology and other diseases. Our Company’s growing and diversified clinical portfolio, built on selection, fit and quality, includes both small and large molecules.

Headquartered in Wilmington, Delaware, United States, Incyte Corporation has operations in Leatherhead, UK, and eight other European countries.